IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q4 2022 Holdings

Filed 2023-01-24 | 7 holdings | $75.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$27.9M3,510,22836.9%
Ventyx Biosciences Inc(VTYX)COM92332V107$24.5M746,37032.4%
Hillevax IncCOM43157M102$9.4M558,92312.4%
Kezar Life Sciences IncCOM49372L100$5.8M828,7117.7%
Talaris Therapeutics IncCOM87410C104$3.0M2,932,6064.0%
Jasper Therapeutics IncCOM471871103$2.8M5,852,9823.7%
Elevation Oncology IncCOM28623U101$2.3M2,370,1423.0%